YopM and Plague

Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 954)

Abstract

YopM is required for full virulence of Yersinia pestis in systemic and bubonic plague, where it functions to counteract innate defenses. Our lab has been using the systemic plague model to identify the immunologic steps at which YopM has its earliest effects and then to work back to the associated signaling pathways affected by YopM. We have found that Gr1+ cells (polymorphonuclear leukocytes (PMNs), monocytes, and some dendritic cells (DCs)) are required to limit the growth of YopMY. pestis. Further, when mice lack the chemokine receptor CCR2, YopMY. pestis grows as well as the parent strain in both systemic and bubonic plague, indicating that YopM’s molecular targets ultimately act through CCR2. YopM disables the recruitment of CCR2+ Gr1+ inflammatory DCs into spleen, whereas in liver, it is the function of CCR2+ Gr1+ PMNs that is undermined. Microarray analysis of transcriptional differences in CD11b+ cells from spleens of mice infected with parent vs. YopMY. pestis points to the downregulation of expression of the transcription factor Egr-1 and of a chemokine ligand for CCR2, CCL2, as effects of YopM initiated by 1 h after infection. These findings provide a link between YopM’s effects at the molecular and immunological levels.

References

  1. Akopyan K, Edgren T, Wang-Edgren H et al (2011) Translocation of surface-localized effectors in type III secretion. Proc Natl Acad Sci U S A 108:1639–1644PubMedCrossRefGoogle Scholar
  2. Benabdillah R, Mota LJ, Lűtzelschwab S et al (2004) Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb Pathog 36:247–261PubMedCrossRefGoogle Scholar
  3. Burnett SH, Kerschen EJ, Zhang J et al (2004) Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J Leukoc Biol 75:612–623PubMedCrossRefGoogle Scholar
  4. Evdokimov AG, Anderson DE, Routzahn KM et al (2000) Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of YopM, an essential virulence factor extruded by the plague bacterium Yersinia pestis. Acta Crystallogr D Biol Crystallogr 56:1676–1679PubMedCrossRefGoogle Scholar
  5. Guha M, O’Connell MA, Pawlinski R et al (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429–1439PubMedCrossRefGoogle Scholar
  6. Hartl D, Krauss-Etschmann S, Koller B et al (2008) Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J Immunol 181:8053–8067PubMedGoogle Scholar
  7. Hines J, Skrzypek E, Kajava AV et al (2001) Structure-function analysis of Yersinia pestis YopM’s interaction with α-thrombin to rule on its significance in systemic plague and to model YopM’s mechanism of binding host proteins. Microb Pathogen 30:193–209CrossRefGoogle Scholar
  8. Kerschen EJ, Cohen DA, Kaplan AM et al (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 72:4589–4602PubMedCrossRefGoogle Scholar
  9. Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11:725–732PubMedCrossRefGoogle Scholar
  10. Kuziel WA, Morgan SJ, Dawson TC et al (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94:12053–12058PubMedCrossRefGoogle Scholar
  11. Lathem WW, Crosby SD, Miller VL et al (2005) Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A 102:17786–17791PubMedCrossRefGoogle Scholar
  12. Lesser CF, Miller SI (2001) Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J 20:1840–1849PubMedCrossRefGoogle Scholar
  13. Leung KY, Straley SC (1989) The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIbα. J Bacteriol 171:4623–4632PubMedGoogle Scholar
  14. Leung KY, Reisner BS, Straley SC (1990) YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect Immun 58:3262–3271PubMedGoogle Scholar
  15. Maekawa T, Takahashi N, Honda T et al (2010) Porphyromonas gingivalis antigens and interleukin-6 stimulate the production of monocyte chemoattractant protein-1 via the upregulation of early growth response-1 transcription in human coronary artery endothelial cells. J Vasc Res 47:346–354PubMedCrossRefGoogle Scholar
  16. Marketon MM, DePaolo RW, DeBord KL et al (2005) Plague bacteria target immune cells during infection. Science 9:1739–1741CrossRefGoogle Scholar
  17. McCoy MW, Marré ML, Lesser CF et al (2010) The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect Immun 78:2584–2598PubMedCrossRefGoogle Scholar
  18. McDonald C, Vacratsis PO, Bliska JB et al (2003) The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J Biol Chem 278:18514–18523PubMedCrossRefGoogle Scholar
  19. McMahon SB, Monroe JG (1996) The role of early growth response gene 1 (egr-1) in regulation of the immune response. J Leuk Biol 60:159–166Google Scholar
  20. McPhee JB, Mena P, Bliska JB (2010) Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infect Immun 78:3529–3539PubMedCrossRefGoogle Scholar
  21. Perry RD, Fetherston JD (2011) Yersisniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis. Microbes Infect 13:808–817PubMedCrossRefGoogle Scholar
  22. Rüter C, Buss C, Scharnert J et al (2010) A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines. J Cell Sci 123:2190–2198PubMedCrossRefGoogle Scholar
  23. Skrzypek E, Straley SC (1996) Interaction between Yersinia pestis YopM protein and human α-thrombin. Thromb Res 84:33–43PubMedCrossRefGoogle Scholar
  24. Skrzypek E, Cowan C, Straley SC (1998) Targeting of the Yersinia pestis yopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol 30:1051–1065PubMedCrossRefGoogle Scholar
  25. Skrzypek E, Myers-Morales T, Whiteheart SW et al (2003) Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eukaryotic cells. Infect Immun 71:937–947PubMedCrossRefGoogle Scholar
  26. Une T, Brubaker RR (1984) In vivo comparison of avirulent Vwa and Pgm or Pstr phenotypes of yersiniae. Infect Immun 43:895–900PubMedGoogle Scholar
  27. Viboud GI, Bliska JB (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59:69–89PubMedCrossRefGoogle Scholar
  28. Ye Z, Kerschen EJ, Cohen DA et al (2009) Gr1+ cells control growth of YopM-negative Yersinia pestis during systemic plague. Infect Immun 77:3791–3806PubMedCrossRefGoogle Scholar
  29. Ye Z, Uittenbogaard AM, Cohen DA et al (2011) Distinct CCR2+ Gr1+ cells control growth of the Yersinia pestis ΔyopM mutant in liver and spleen during systemic plague. Infect Immun 79:674–687PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Microbiology, Immunology, and Molecular GeneticsUniversity of KentuckyLexingtonUSA

Personalised recommendations